Skip to main content
    M

    Merck & Company Inc (MRK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $143.39
    -1.07 (-0.74%)

    Market Cap: $356.13B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Merck & Company Inc (MRK) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Merck & Company (MRK) has a market cap of $356.13B and an enterprise value of $400.36B. Its trailing P/E of 46.0x is above its 10-year median of 15.3x. Its return on invested capital of 3.14% compares with a 13.95% median across 11 similar companies.

    Total Valuation

    Enterprise value is 12.42% above the market cap, as debt exceeds cash.

    Market Cap$356.13B
    Enterprise Value$400.36B
    Latest price (Nov 17, 2026)$143.39

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 15, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Last Ex-Dividend DateSep 15, 2026
    Last Payment DateOct 7, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.08% in the quarter ended Sep 30, 2026 and shrank 1.28% a year over 2 years.

    Shares Outstanding2.47B
    Shares Change (YoY)-0.68%
    Shares Change (QoQ)-0.08%
    Share Count Growth (2Y CAGR)-1.28%

    Valuation Ratios

    Sales and book value multiples are 5.2x and 7.9x. Its year-end P/E ranged from 11.7x to 72.7x from 2016 to 2025.

    P/E Ratio46.0x
    Forward P/E50.9x
    P/S Ratio5.2x
    Forward P/S5.3x
    P/B Ratio7.9x
    P/FCF Ratio24.0x
    P/OCF Ratio19.0x
    PEG Ratio18.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 32.9x EBITDA and 27.0x free cash flow.

    EV / Earnings163.4x
    EV / Sales5.9x
    EV / EBITDA32.9x
    EV / EBIT84.1x
    EV / FCF27.0x

    Price Statistics

    The stock is up 56.77% over 52 weeks and trades 1.69% below its 50-day average.

    Beta (1Y)0.25
    52-Week Change+56.77%
    1-Month Change-0.17%
    3-Month Change-5.23%
    6-Month Change+27.19%
    5-Year Change+69.81%
    10-Year Change+154.63%
    Total Return (1Y)+60.49%
    Total Return (3Y CAGR)+14.48%
    Total Return (5Y CAGR)+14.34%
    Return vs SPY (1Y)+39.50%
    Max Drawdown (1Y)-11.89%
    Max Drawdown (3Y)-43.45%
    Sharpe Ratio (1Y)1.41
    Correlation with SPY (1Y)0.12
    50-Day Average$145.85
    200-Day Average$128.09
    52-Week Range$91.22 to $156.00
    RSI (14 Days)45.0
    Average Volume (20 Days)9.43M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.35x current liabilities, and total debt is 1.20x shareholder equity.

    Current Ratio1.35x
    Quick Ratio1.14x
    Debt / Equity1.20x
    Debt / EBITDA4.44x
    Debt / FCF3.65x

    Returns and Efficiency

    Return on invested capital is 3.14% over the last 12 months, against a 5-year average of 15.28%.

    Return on Equity (ROE)5.46%
    Return on Assets (ROA)1.85%
    Return on Invested Capital (ROIC)3.14%
    Return on Capital Employed (ROCE)4.58%
    ROE (5Y Average)27.69%
    ROA (5Y Average)10.80%
    ROIC (5Y Average)15.28%
    Asset Turnover0.51x
    Inventory Turnover3.08x
    Receivables Turnover5.32x
    Cash Conversion Cycle102 days

    Taxes

    Income tax took 48.55% of pretax income over the last 12 months.

    Income Tax (TTM)$2.31B
    Effective Tax Rate48.55%

    Scores

    MRK has an Altman Z-Score of 3.83, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score3.83
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $67.38B over the last 12 months is up 4.89% from the 12 months before.

    Revenue$67.38B
    Revenue Growth (YoY)+4.89%
    Gross Profit$48.34B
    Operating Income$5.46B
    Pretax Income$4.76B
    Net Income$2.45B
    EBITDA$12.11B
    EBIT$4.76B
    Reported EPS (TTM)$3.12

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 33.81% of the $132.77B in total assets.

    Cash and Equivalents$9.55B
    Total Debt$53.78B
    Net Debt$44.23B
    Net Debt Per Share$17.94
    Working Capital$10.14B
    Shareholder Equity$44.89B
    Book Value Per Share$18.21
    Tangible Book Value-$1.53B
    Total Assets$132.77B
    Total Liabilities$87.83B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.96B of capital spending, operating cash flow left $14.75B of free cash flow.

    Operating Cash Flow$18.70B
    Capital Expenditures$3.96B
    Free Cash Flow$14.75B
    FCF Per Share$5.98
    Depreciation and Amortization$7.34B
    Dividends Paid$8.37B
    Share Repurchases$3.54B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 8.10%, against a 5-year average of 24.72%.

    Gross Margin71.75%
    Operating Margin8.10%
    Pretax Margin7.07%
    Net Margin3.64%
    EBITDA Margin17.97%
    EBIT Margin7.07%
    FCF Margin21.89%
    Gross Margin (5Y Average)73.39%
    Operating Margin (5Y Average)24.72%
    Net Margin (5Y Average)21.34%

    Growth

    Revenue grew 3.12% a year over 3 years, and EPS 6.24% a year.

    Revenue Growth (3Y CAGR)+3.12%
    Revenue Growth (5Y CAGR)+9.38%
    EPS Growth (3Y CAGR)+6.24%
    EPS Growth (5Y CAGR)+8.63%
    FCF Growth (3Y CAGR)-5.63%
    FCF Growth (5Y CAGR)+31.13%
    Operating Income Growth (3Y CAGR)+5.74%
    Book Value Per Share Growth (2Y CAGR)+19.88%

    Revenue and profit by year

    Dividends and Yields

    MRK pays out 44.82% of earnings as dividends.

    Dividend Per Share (Annual)$3.40
    Dividend Yield2.37%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+5.42%
    Dividend Growth (5Y CAGR)+5.75%
    Payout Ratio44.82%
    FCF Payout Ratio56.73%
    Earnings Yield2.17%
    FCF Yield4.17%
    Buyback Yield1.00%
    Shareholder Yield3.37%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Feb 17, 1999.

    Last Split DateFeb 17, 1999
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 9 similar companies, MRK has the highest P/E.

    P/E Ratio46.0x vs 19.8x median
    P/S Ratio5.2x vs 5.0x median
    ROIC3.14% vs 13.95% median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.89% vs +7.17% median
    Dividend Yield2.37% vs 2.68% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.37% and EPS growth at 0.06% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.37%
    EPS Growth Forecast (2Y CAGR)+0.06%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MRK

    What is MRK's market cap?

    Merck & Company has a market cap of $356.13B. Its enterprise value, which adds debt and subtracts cash, is $400.36B.

    What is MRK's P/E ratio?

    Merck & Company has a trailing P/E ratio of 46.0x and a forward P/E of 50.9x.

    How many shares of MRK are outstanding?

    Merck & Company has 2.47B shares outstanding. The count is down 0.68% from a year earlier.

    Does MRK pay a dividend?

    Yes. Merck & Company pays $3.40 a share a year, a dividend yield of 2.37%.

    How much debt does MRK have?

    Merck & Company has $53.78B of total debt and $9.55B of cash and equivalents, a net debt position of $44.23B.